Michael G. Rosenfeld

Michael G. Rosenfeld

Auto-generated profile, based on publicly available information

Michael G. Rosenfeld

Department and School of Medicine, University of California San Diego

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2013 in Nature
Verified
Journal Article
Closed access
PDF file
WLWenbo Li
Wenbo Li
DNDimple Notani
Dimple Notani
QMQi Ma
Qi Ma
BTBogdan Tanasa
Bogdan Tanasa
ENEsperanza Nunez
Esperanza Nunez
MRMichael G. Rosenfeld
Michael G. Rosenfeld

23 June 2006 in Science
Verified
Journal Article
Closed access
PDF file
BJBong-Gun Ju
Bong-Gun Ju
VLVictoria V. Lunyak
Victoria V. Lunyak
VPValentina Perissi
Valentina Perissi
IGIvan Garcia-Bassets
Ivan Garcia-Bassets
DRDavid W. Rose
David W. Rose
MRMichael G. Rosenfeld
Michael G. Rosenfeld
Multiple enzymatic activities are required for transcriptional initiation. The enzyme DNA topoisomerase II associates with gene promoter regions and can generate breaks in double-stranded DNA (dsDNA). Therefore, it is of interest to know whether this enzyme is critical for regulated gene activation. We report that the signal-dependent activation of gene transcription by nuclear receptors and other classes of DNA binding transcription factors, including activating protein 1, requires DNA topoisomerase IIβ-dependent, transient, site-specific dsDNA break formation. Subsequent to the break, poly(adenosine diphosphate–ribose) polymerase–1 enzymatic activity is induced, which is required for a nucleosome-specific histone H1–high-mobility group B exchange event and for local changes of chromatin architecture. Our data mechanistically link DNA topoisomerase IIβ–dependent dsDNA breaks and the components of the DNA damage and repair machinery in regulated gene transcription.

1 June 2006 in Genes & Development
Verified
Journal Article
Open access
PDF file
MRMichael G. Rosenfeld
Michael G. Rosenfeld
VLVictoria V. Lunyak
Victoria V. Lunyak
CGChristopher K. Glass
Christopher K. Glass
A decade of intensive investigation of coactivators and corepressors required for regulated actions of DNA-binding transcription factors has revealed a network of sequentially exchanged cofactor complexes that execute a series of enzymatic modifications required for regulated gene expression. These coregulator complexes possess “sensing” activities required for interpretation of multiple signaling pathways. In this review, we examine recent progress in understanding the functional consequences of “molecular sensor” and “molecular adaptor” actions of corepressor/coactivator complexes in integrating signal-dependent programs of transcriptional responses at the molecular level. This strategy imposes a temporal order for modifying programs of transcriptional regulation in response to the cellular milieu, which is used to mediate developmental/homeostatic and pathological events.

15 May 2011 in Nature
Verified
Journal Article
Open access
PDF file
DWDong Wang
Dong Wang
IGIvan Garcia-Bassets
Ivan Garcia-Bassets
CBChris Benner
Chris Benner
WLWenbo Li
Wenbo Li
XSXue Su
Xue Su
XFXiang-Dong Fu
Xiang-Dong Fu
Transcriptional enhancers orchestrate cell-type-specific gene expression programs, but how they convey signal-activated transcriptional responses remains poorly understood. Here, the cell-lineage-specific transcription factor FoxA1 is shown to both facilitate and restrict the androgen receptor to act on distinct classes of enhancers. Lowered levels of FoxA1, such as those found in prostate cancer, can reprogram the hormonal response by causing a switch in androgen receptor binding to a set of pre-established, functional enhancers that are marked by enhancer-derived non-coding RNAs (eRNAs). This work points to the existence of a large repository of active enhancers that can be tuned to allow alternative gene expression programs in normal cell development and in disease progression. Mammalian genomes are populated with thousands of transcriptional enhancers that orchestrate cell-type-specific gene expression programs1,2,3,4, but how those enhancers are exploited to institute alternative, signal-dependent transcriptional responses remains poorly understood. Here we present evidence that cell-lineage-specific factors, such as FoxA1, can simultaneously facilitate and restrict key regulated transcription factors, exemplified by the androgen receptor (AR), to act on structurally and functionally distinct classes of enhancer. Consequently, FoxA1 downregulation, an unfavourable prognostic sign in certain advanced prostate tumours, triggers dramatic reprogramming of the hormonal response by causing a massive switch in AR binding to a distinct cohort of pre-established enhancers. These enhancers are functional, as evidenced by the production of enhancer-templated non-coding RNA (eRNA5) based on global nuclear run-on sequencing (GRO-seq) analysis6, with a unique class apparently requiring no nucleosome remodelling to induce specific enhancer–promoter looping and gene activation. GRO-seq data also suggest that liganded AR induces both transcription initiation and elongation. Together, these findings reveal a large repository of active enhancers that can be dynamically tuned to elicit alternative gene expression programs, which may underlie many sequential gene expression events in development, cell differentiation and disease progression.

14 August 2013 in Nature
Verified
Journal Article
Open access
PDF file
Liuqing YangLiuqing Yang
Liuqing Yang
Chunru LinChunru Lin
Chunru Lin
CJChunyu Jin
Chunyu Jin
JYJoy C. Yang
Joy C. Yang
BTBogdan Tanasa
Bogdan Tanasa
MRMichael G. Rosenfeld
Michael G. Rosenfeld
A study of prostate cancer cells reveals a transcriptional activation role for long non-coding RNAs (PRNCR1 and PCGEM1) that bind to the androgen receptor, and is also observed for the truncated androgen receptor characteristic of many aggressive prostate cancers. Several long non-coding RNAs (lncRNAs) are known to be overexpressed in prostate cancer. Michael Rosenfeld and colleagues have investigated the mechanistic and biological roles of two of these, known as PRNCR1 and PCGEM1. Both are found to interact with the androgen receptor (AR) dependent on specific post-translational modifications, and to enhance the looping of AR-bound enhancers to target gene promoters, leading to enhanced gene expression. They also enhance AR-mediated proliferation in prostate cancer cells and are required for tumour growth in a prostate cancer xenograft mouse model. PRNCR1 and PCGEM1 are upregulated in castration-resistant prostate cancer cell lines. The regulatory roles of lncRNAs in prostate cancer uncovered in this manuscript may open the way to new therapeutic approaches. Although recent studies have indicated roles of long non-coding RNAs (lncRNAs) in physiological aspects of cell-type determination and tissue homeostasis1, their potential involvement in regulated gene transcription programs remains rather poorly understood. The androgen receptor regulates a large repertoire of genes central to the identity and behaviour of prostate cancer cells2, and functions in a ligand-independent fashion in many prostate cancers when they become hormone refractory after initial androgen deprivation therapy3. Here we report that two lncRNAs highly overexpressed in aggressive prostate cancer, PRNCR1 (also known as PCAT8) and PCGEM1, bind successively to the androgen receptor and strongly enhance both ligand-dependent and ligand-independent androgen-receptor-mediated gene activation programs and proliferation in prostate cancer cells. Binding of PRNCR1 to the carboxy-terminally acetylated androgen receptor on enhancers and its association with DOT1L appear to be required for recruitment of the second lncRNA, PCGEM1, to the androgen receptor amino terminus that is methylated by DOT1L. Unexpectedly, recognition of specific protein marks by PCGEM1-recruited pygopus 2 PHD domain enhances selective looping of androgen-receptor-bound enhancers to target gene promoters in these cells. In ‘resistant’ prostate cancer cells, these overexpressed lncRNAs can interact with, and are required for, the robust activation of both truncated and full-length androgen receptor, causing ligand-independent activation of the androgen receptor transcriptional program and cell proliferation. Conditionally expressed short hairpin RNA targeting these lncRNAs in castration-resistant prostate cancer cell lines strongly suppressed tumour xenograft growth in vivo. Together, these results indicate that these overexpressed lncRNAs can potentially serve as a required component of castration-resistance in prostatic tumours.

20 May 2009 in Nature
Verified
Journal Article
Open access
PDF file
MTMichele Trabucchi
Michele Trabucchi
PBPaola Briata
Paola Briata
MGMariaFlor Garcia-Mayoral
MariaFlor Garcia-Mayoral
AHAstrid D. Haase
Astrid D. Haase
WFWitold Filipowicz
Witold Filipowicz
MRMichael G. Rosenfeld
Michael G. Rosenfeld
As small RNAs exert profound effects on development and regulation of gene expression, their own expression must be similarly constrained to the right level in the right cell at the right time. A collaboration between the labs of Michael Rosenfeld and Witold Filipowicz reports that the RNA-binding protein KSRP (KH-type splicing regulatory protein) regulates the precursor processing of a subset of microRNAs. If this regulatory mechanism is disrupted, effects can be seen on proliferation, differentiation and apoptosis. Thus KSRP is involved in both mRNA turnover and in promoting mRNA expression. This work has uncovered a further level of complexity in the regulation of gene expression by mi-RNA. MicroRNAs (miRNAs) have a role in down-regulating gene expression, and the levels of specific miRNAs are important for correct embryonic development; however, the mechanisms by which this is regulated are unknown. The splicing regulatory protein, KSRP, is now found to regulate the precursor processing of a subset of miRNAs, and its disruption leads to effects on proliferation, differentiation and apoptosis. Consistent with the role of microRNAs (miRNAs) in down-regulating gene expression by reducing the translation and/or stability of target messenger RNAs1, the levels of specific miRNAs are important for correct embryonic development and have been linked to several forms of cancer2,3,4. However, the regulatory mechanisms by which primary miRNAs (pri-miRNAs) are processed first to precursor miRNAs (pre-miRNAs) and then to mature miRNAs by the multiprotein Drosha and Dicer complexes5,6,7,8, respectively, remain largely unknown. The KH-type splicing regulatory protein (KSRP, also known as KHSRP) interacts with single-strand AU-rich-element-containing mRNAs and is a key mediator of mRNA decay9,10. Here we show in mammalian cells that KSRP also serves as a component of both Drosha and Dicer complexes and regulates the biogenesis of a subset of miRNAs. KSRP binds with high affinity to the terminal loop of the target miRNA precursors and promotes their maturation. This mechanism is required for specific changes in target mRNA expression that affect specific biological programs, including proliferation, apoptosis and differentiation. These findings reveal an unexpected mechanism that links KSRP to the machinery regulating maturation of a cohort of miRNAs that, in addition to its role in promoting mRNA decay, independently serves to integrate specific regulatory programs of protein expression.